Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Molecular Probe Identifies Proteins Related to Aging Conditions

By LabMedica International staff writers
Posted on 04 Sep 2009
Scientists have developed a powerful new probe for identifying proteins affected by a key chemical process in aging and disease. More...
The probe works like a molecular navigation system for finding the proteins in cells. It could lead to new insights into disease processes and identify new targets for disease treatments.

The technology developed by the scientists has applications in both diagnostics (protein biomarkers), and in clinical medicine where it has a role in inhibition of enzymes implicated in diseases such as cancer and diabetes.

A new molecule called DAz-2 was developed that quickly finds specific proteins affected by reactive oxygen species (ROS). The molecules do this by chemically "tagging” sulfenic acid. Formed in cells, sulfenic acid indicates that a protein has undergone an oxidation reaction caused by the ROS. In laboratory studies using cultured cells, the scientists identified more than 190 proteins that had undergone this reaction.

Kate Carroll and colleagues from the chemistry department, University of Michigan (Ann Arbor, MI, USA) noted that scientists have known for years that the excess build-up of highly-reactive oxygen-containing molecules in cells contribute to aging disorders, possibly even cancer and Alzheimer's disease (AD). Many believe that a diet rich in antioxidants, which are abundant in fruits and vegetables, help deter this cell-damaging process by blocking the accumulation of these ROS molecules. But scientists have lacked the proper tools to study the effects of these molecules in detail.

The study is scheduled for publication in the September 18, 2009, issue of the American Chemical Society (ACS) journal Chemical Biology.

Related Links:

Chemistry department, University of Michigan




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
Platelet Function Analyzer
PL-12
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.